AURORA 1 (2021) — Trial Summary
AURORA 1 (2021): Evaluated the efficacy and safety of voclosporin in adults with active lupus nephritis.
References
- Rovin BH, Teng YKO, Ginzler EM, et al. Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2021;397(10289):2070-2080.